Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and Non-Hodgkin Lymphoma with B-cell or T-cell Origin
A59311
Allogeneic hematopoietic cell transplantation is locally covered for primary refractory or relapsed Hodgkin and non-Hodgkin lymphoma of B- or T-cell origin. Coverage requires a documented pretransplant evaluation (history/physical, relevant labs, chest radiograph, ECG, cardiac function study, pulmonary function tests, and disease-specific restaging) or documented completion of an institution’s pre-transplant protocol, plus documented pretransplant counseling and individualized informed consent. Documentation must be present in the medical record to support billing and available on request; refer to NCD 110.23 and LCD DL39513 for the nationally covered indications and additional requirements.
"Allogeneic hematopoietic cell transplantation (HCT) is covered for individuals with primary refractory or relapsed Hodgkin lymphoma of B-cell or T-cell origin."
Sign up to see full coverage criteria, indications, and limitations.